iRhythm Q3 2026 EPS Tops Estimates at $0.82, but Revenue Misses at $221.6M

iRhythm (IRTC) posted mixed third-quarter 2026 results, with adjusted EPS above the estimate and revenue below it. Revenue was $221.6 million, up 15% from a year earlier, below the $222.2 million estimate, and adjusted EPS was $0.82 above the $0.02 estimate.

Shares were unchanged in after-hours trading as of 4:04 p.m. ET, to $130.19 from a $130.19 close.

Q3 2026 scorecard

By our calculation, revenue was $642 thousand below the estimate and adjusted EPS was $0.80 above it. The QoQ column compares with the previous quarter's revenue of $224.2 million and adjusted EPS of -$0.01. The YoY column compares with $192.9 million and -$0.16 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 7 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 7 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $192.9 million, $208.9 million, $199.4 million, $224.2 million and $221.6 million.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $0.23 and revenue of $244.6 million next quarter, based on 3 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 15% increase to $221.6 million.
• Estimate record. Whether iRhythm extends a record of beating EPS estimates in 7 of its last 8 reports.
• Related coverage. See our reports on Eton Pharmaceuticals, BlackLine, BJ's Restaurants and Federal Agricultural Mortgage.

Sources: Results are from iRhythm's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from iRhythm's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.